(1) To obtain objective information about levetiracetam transplacental passage and its transport into colostrum, mature milk, and breastfed infants, we analyzed data from women treated for epilepsy between October 2006 and January 2021; (2) in this cohort study, maternal, umbilical cord, milk, and infant serum concentrations were measured at delivery, 2-4 days postpartum (colostrum) and 7-31 days postpartum (mature milk). Paired umbilical cord serum, maternal serum, breastfed infant serum, and milk concentrations were used to assess the ratios of umbilical cord/maternal serum, milk/maternal serum, and infant/maternal serum concentrations. The influence of combined treatment with enzyme-inducing antiseizure medication carbamazepine was assessed; (3) the umbilical cord/maternal serum concentration ratio ranged between 0.75 and 1.78 (mean 1.10 ± 0.33), paired maternal and umbilical cord serum concentrations were not significantly different, and a highly significant correlation was found between both concentrations. The mean milk/maternal serum concentration ratio was 1.14 ± 0.27 (2-4 days postpartum) and 1.04 ± 0.24 (7-31 days postpartum) while the mean infant/maternal serum concentration ratio was markedly lower (0.19 ± 0.13 and 0.14 ± 0.05, respectively); (4) levetiracetam was found in the umbilical cord at a concentration similar to those in maternal serum. All of the breastfed infant serum concentrations were below the reference range used for the general epileptic population.

Department of Clinical Pharmacology Department of Laboratory Medicine University Hospital Ostrava 70852 Ostrava Czech Republic

Department of Clinical Pharmacology Faculty of Medicine University of Ostrava 70300 Ostrava Czech Republic

Zobrazit více v PubMed

EURAP—An International Antiepileptic Drugs and Pregnancy Registry. Interim Report, November 2020. [(accessed on 19 February 2021)]; Available online: https://eurapinternational.org/wp-content/uploads/2020/01/EurapReport_NOV-2019.pdf.

Kacirova I., Grundmann M. Trend analysis of the utilization of antiepileptic drugs in pregnant women with epilepsy in Moravian-Silesian region of the Czech Republic. Klin. Farmakol. Farm. 2016;30:23–28.

Voinescu P.E., Park S., Chen L.Q., Stowe Z.N., Newport D.J., Ritchie J.C., Pennell P.B. Antiepileptic drug clearances during pregnancy and clinical implications for women with epilepsy. Neurology. 2018;91:e1228–e1236. doi: 10.1212/WNL.0000000000006240. PubMed DOI PMC

Tomson T., Palm R., Källén K., Ben-Menachem E., Söderfeldt B., Danielsson B., Johansson R., Luef G., Öhman I. Pharmacokinetics of Levetiracetam during Pregnancy, Delivery, in the Neonatal Period, and Lactation. Epilepsia. 2007;48:1111–1116. doi: 10.1111/j.1528-1167.2007.01032.x. PubMed DOI

Westin A.A., Reimers A., Helde G., Nakken K.O., Brodtkorb E. Serum concentration/dose ratio of levetiracetam before, during and after pregnancy. Seizure. 2008;17:192–198. doi: 10.1016/j.seizure.2007.11.027. PubMed DOI

Reisinger T., Newman M., Loring D., Pennell P., Meador K. Antiepileptic drug clearance and seizure frequency during pregnancy in women with epilepsy. Epilepsy Behav. 2013;29:13–18. doi: 10.1016/j.yebeh.2013.06.026. PubMed DOI PMC

Johannessen S.I., Helde G., Brodtkorb E. Levetiracetam Concentrations in Serum and in Breast Milk at Birth and during Lactation. Epilepsia. 2005;46:775–777. doi: 10.1111/j.1528-1167.2005.54804.x. PubMed DOI

Johannessen S.I., Helde G., Brodtkorb E. Levetiracetam in pregnancy and lactation: Preliminary observation. Epilepsia. 2004;45(Suppl. 3):58.

Dinavitser N., Kohn E., Berlin M. Levetiracetam monitoring in breast-milk: High inter-individual variability. Arch. Dis. Child. 2019;104:14. doi: 10.1136/archdischild-2019-esdppp.31. DOI

Bank A.M., Stowe Z.N., Newport D.J., Ritchie J.C., Pennell P.B. Placental passage of antiepileptic drugs at delivery and neonatal outcomes. Epilepsia. 2017;58:e82–e86. doi: 10.1111/epi.13733. PubMed DOI PMC

Ylikotila P., Ketola R.A., Timonen S., Malm H., Ruuskanen J.O. Early pregnancy cerebral venous thrombosis and status epilepticus treated with levetiracetam and lacosamide throughout pregnancy. Reprod. Toxicol. 2015;57:204–206. doi: 10.1016/j.reprotox.2015.07.068. PubMed DOI

López-Fraile I.P., Cid A.O., Juste A.O., Modrego P.J. Levetiracetam plasma level monitoring during pregnancy, delivery, and postpartum: Clinical and outcome implications. Epilepsy Behav. 2009;15:372–375. doi: 10.1016/j.yebeh.2009.04.006. PubMed DOI

Kramer G., Hosli I., Glanzmann R. Levetiracetam accumulation in human breast milk. Epilepsia. 2002;43(Suppl. 7):105.

Greenhill L., Betts T., Yarrow H. Breast milk levels of levetiracetam after delivery. Epilepsia. 2004;45(Suppl. 7):230. doi: 10.1111/j.0013-9580.2004.t01-21-00001.x. PubMed DOI

Kohn E., Brandriss N., Soback S., Bar-Haim A., Berkovitch M. Levetiracetam and lamotrigine excretion in breast milk. Reprod. Toxicol. 2016;60:184. doi: 10.1016/j.reprotox.2016.03.032. DOI

Paret N., Gouraud A., Bernard N. Long-term follow-up of infants exposed to levetiracetam during breastfeeding: Comparison to a control group. Birth Defects Res. Clin. Mol. Teratol. 2014;100:537–538.

Birnbaum A.K., Meador K.J., Karanam A., Brown C., May R.C., Gerard E.E., Gedzelman E.R., Penovich P.E., Kalayjian L.A., Cavitt J., et al. Antiepileptic Drug Exposure in Infants of Breastfeeding Mothers with Epilepsy. JAMA Neurol. 2020;77:441–450. doi: 10.1001/jamaneurol.2019.4443. PubMed DOI PMC

The Drug and Lactation Database (LACTMED), a Database of the National Library of Medicine’s TOXNET System. [(accessed on 19 February 2021)]; Available online: https://toxnet.nlm.nih.gov/

Patsalos P.N., Spencer E.P., Berry D.J. Therapeutic Drug Monitoring of Antiepileptic Drugs in Epilepsy: A 2018 Update. Ther. Drug Monit. 2018;40:526–548. doi: 10.1097/FTD.0000000000000546. PubMed DOI

Keizer R.J., Jansen R.S., Rosing H., Thijssen B., Beijnen J.H., Schellens J.H.M., Huitema A.D.R. Incorporation of concentration data below the limit of quantification in population pharmacokinetic analyses. Pharmacol. Res. Perspect. 2015;3:e00131. doi: 10.1002/prp2.131. PubMed DOI PMC

Johnson E.L., Stowe Z.N., Ritchie J.C., Newport D.J., Newman M.L., Knight B., Pennell P.B. Carbamazepine clearance and seizure stability during pregnancy. Epilepsy Behav. 2014;33:49–53. doi: 10.1016/j.yebeh.2014.02.011. PubMed DOI PMC

Patel S.I., Pennell P.B. Management of epilepsy during pregnancy: An update. Ther. Adv. Neurol. Disord. 2016;9:118–129. doi: 10.1177/1756285615623934. PubMed DOI PMC

Sharpe C.M., Capparelli E.V., Mower A., Farrell M.J., Soldin S.J., Haas R.H. A seven-day study of the pharmacokinetics of intravenous levetiracetam in neonates: Marked changes in pharmacokinetics occur during the first week of life. Pediatr. Res. 2012;72:43–49. doi: 10.1038/pr.2012.51. PubMed DOI

Merhar S.L., Schibler K.R., Sherwin C.M., Meinzen-Derr J., Shi J., Balmakund T., Vinks A.A. Pharmacokinetics of Levetiracetam in Neonates with Seizures. J. Pediatr. 2011;159:152–154.e3. doi: 10.1016/j.jpeds.2011.03.057. PubMed DOI PMC

Mruk A.L., Garlitz K.L., Leung N.R. Levetiracetam in Neonatal Seizures: A Review. J. Pediatr. Pharmacol. Ther. 2015;20:76–89. doi: 10.5863/1551-6776-20.2.76. PubMed DOI PMC

Nicolas J.-M., Bouzom F., Hugues C., Ungell A.-L. Oral drug absorption in pediatrics: The intestinal wall, its developmental changes and current tools for predictions. Biopharm. Drug Dispos. 2017;38:209–230. doi: 10.1002/bdd.2052. PubMed DOI PMC

Valproic Acid Concentrations in Mothers, Colostrum and Breastfed Infants during the Early Postpartum Period: Comparison with Concentrations Determined during Delivery and in the Mature Milk Period